Serial 98298240
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98298240
- Registration number
- 7591751
- Mark type
- Design / logo
- Filed
- 04 Dec 2023
- Published for opposition
- 18 Jun 2024
- Registered
- 03 Dec 2024
- Attorney of record
- Melissa A. Nowak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research
- Class 044 — Medical, beauty and agricultural services: Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders
Owner
- Revolution Medicines, Inc., Redwood City, CA, US
- Revolution Medicines, Inc., Redwood City, CA, US
- Revolution Medicines, Inc., Redwood City, CA, US
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Nov 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Sept 2024 — USE AMENDMENT FILED
- 08 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 13 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2024 — PUBLISHED FOR OPPOSITION
- 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 10 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED